Valuation: Adocia

Market Cap 74.55M 85.3M 68.79M 63.41M 120M 8.21B 122M 822M 323M 4.02B 320M 313M 13.85B P/E 2026 *
15.4x
P/E 2027 * 7.65x
Enterprise Value 44.7M 51.15M 41.25M 38.02M 71.66M 4.93B 73.26M 493M 194M 2.41B 192M 188M 8.31B EV / Sales 2026 *
3.58x
EV / Sales 2027 * 3.25x
Free-Float
95.03%
Yield 2026 *
-
Yield 2027 * -
1 day-1.85%
1 week+1.87%
Current month-7.97%
1 month-11.40%
3 months-26.16%
6 months-37.02%
Current year-43.13%
1 week 3.61
Extreme 3.61
3.92
1 month 3.61
Extreme 3.61
4.53
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Date Insider Type Main position Quantity % Market Cap.
27/02/25 Buy

Founder

109,170 0.6972%
06/04/24 Buy

Founder

15,576 0.1105%
06/04/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%+1.87%-15.71%-1.93% 85.3M
-7.17%-4.39%+45.51%+79.00% 52.1B
+0.24%-1.54%+53.22%+71.85% 53.83B
+0.80%-6.31%+3.98%+423.29% 23.48B
-0.09%-0.01%-17.62%-14.67% 23.13B
-5.95%-2.58%+30.67%-9.58% 19.36B
-1.14%+0.03%+31.57%-30.42% 17.56B
-5.16%-7.00%+168.44%+306.37% 15.2B
-6.91%-5.83%+26.53%+636.97% 14.83B
+0.43%-1.03%+24.63%+191.40% 14.06B
Average -2.68%-2.18%+35.12%+165.23% 23.36B
Weighted average by Cap. -2.80%-2.35%+40.10%+144.05%

Financials

2026 *2027 *
Net sales 12.5M 14.3M 11.53M 10.63M 20.04M 1.38B 20.48M 138M 54.23M 675M 53.72M 52.54M 2.32B 32.26M 36.91M 29.76M 27.44M 51.71M 3.55B 52.86M 356M 140M 1.74B 139M 136M 5.99B
Net income -518K -593K -478K -440K -830K -57.07M -849K -5.71M -2.25M -27.95M -2.23M -2.18M -96.21M -47.3M -54.13M -43.65M -40.24M -75.84M -5.21B -77.52M -522M -205M -2.55B -203M -199M -8.79B
Net Debt -29.84M -34.15M -27.54M -25.38M -47.84M -3.29B -48.91M -329M -129M -1.61B -128M -125M -5.54B 30.18M 34.53M 27.85M 25.67M 48.38M 3.33B 49.45M 333M 131M 1.63B 130M 127M 5.61B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
17/07/26 €3.810 -1.85% 60,719
16/07/26 €3.882 -0.97% 48,599
15/07/26 €3.920 +1.66% 57,642
14/07/26 €3.856 +3.16% 117,291
13/07/26 €3.738 -0.05% 66,472
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.810EUR
Average target price
10.70EUR
Spread / Average Target
+180.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock